Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at
the UBS Global Life Sciences Conference will be webcast live on Monday,
September 19, 2011 at 11:30 a.m. ET. To access the live webcast, please
visit Biogen Idec's Investor Relations section
(investor.biogenidec.com). An archived version of the webcast will be
available for 14 days following the presentation.
About Biogen Idec
Biogen Idec uses cutting-edge science to discover, develop, manufacture
and market therapies for serious diseases with a focus on neurology,
immunology and hemophilia. Founded in 1978, Biogen Idec is the world's
oldest independent biotechnology company. Patients worldwide benefit
from its leading multiple sclerosis therapies, and the company generates
more than $4 billion in annual revenues. For product labeling, press
releases and additional information about the company, please visit www.biogenidec.com.